Abstract
The effect of glucose variability on the development of chronic critical illness and mortality in critically-ill COVID-19 patients
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have